3 weeks ago 732

New Paxlovid study data, monkeypox cases, U.S. life expectancy and more with Andrea Garcia, JD, MPH


Free COVID tests, vaccines and treatments could be ending soon. AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also covers the continued decline in U.S. life expectancy and FDA's authorization of Moderna and Pfizer boosters for fall. American Medical Association CXO Todd Unger hosts. 0:00 AMA Update for Sept. 7, 2022 0:40 FDA authorized two COVID boosters (Pfizer-BioNTech, Moderna) 1:27 New boosters target BA.4 and BA.5 Omicron subvariants 2:23 Pfizer booster for adults and children as young as 12 2:31 Moderna booster for adults 18 and older only 2:45 Fall booster shots available this week, according to NYT 3:40 New CPT codes for COVID boosters already available 4:35 COVID cases in the U.S. 5:10 COVID-19 hospitalizations and deaths 6:08 U.S. life expectancy decline continues 6:43 Native Americans, Alaska Natives life expectancy falls 4 years, reports NCHS 7:35 Free COVID-19 vaccines, tests, treatments to end January 2023, says Biden Administration 8:47 Uninsured may lose COVID coverage due to lack of federal funding 9:23 Israel Paxlovid study results 10:07 New findings from Paxlovid study data 11:18 Monkeypox cases in the U.S.
Read Entire Article

Comments

Get the most out of News by signing in
Sign In Register